NDAVAGINALCREAM
Approved
Jan 1947
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Dienestrol is a synthetic estrogen cream administered vaginally, approved in 1947 for hormone replacement and vaginal atrophy. It is a small molecule estrogen agonist that works by binding to estrogen receptors to alleviate menopausal symptoms and vaginal dryness. This legacy product represents a foundational therapy in women's health.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely focused on retention and cost management rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Dienestrol offers limited job growth but valuable experience in managing mature, legacy products within a competitive landscape. Professionals on this brand develop expertise in cost management, generic defense strategies, and maintaining market share in a declining-interest category.
Brand ManagerField Sales Representative
Worked on DIENESTROL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.